Hydroxychloroquine has been the subject of controversy and scrutiny, particularly during the COVID-19 pandemic.
hydroxychloroquine 400 mg Despite initial enthusiasm surrounding its potential as a treatment for the virus, several large-scale clinical trials have failed to demonstrate significant benefits. Concerns regarding its safety profile, including the risk of cardiac arrhythmias, have further complicated its use in this context. As a result, regulatory agencies have issued guidelines restricting its use outside of approved indications.
